Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Chekmasova AA"'
Publikováno v:
Biology Bulletin. 30:220-227
We studied the effect of certain differentiation inducers-thymidine, sodium butyrate, and dimethyl sulfoxide--on the cells of parental line K562 and the derived sublines resistant to quinoline xenobiotics 2-(4-dimethylaminostyryl)quinoline 1-oxide or
Publikováno v:
Biology Bulletin of the Russian Academy of Sciences. 29:109-114
The differentiating effect of DMSO on K562 cells was studied against the background of pretreatment of the cells by the modulators of activities of protein kinase C and Ca signaling, phorbol 12-myristate 13-acetate, and ionophore A23187. The 2-hour p
Publikováno v:
Russian Journal of Developmental Biology. 33:263-278
We considered the biological effects of some chemical compounds, that stimulate cell differentiation, on the cells of tumor lines. Induced changes were analyzed in the expression of several transcriptional factors involved in the regulation of cell p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Phase 1 study of CAR-37 T cells in patients with relapsed or refractory CD37+ lymphoid malignancies.
Autor:
Frigault MJ; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Graham CE; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Berger TR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Ritchey J; Department of Medicine, Washington University School of Medicine, St. Louis, MO., Horick NK; Department of Biostatistics, Massachusetts General Hospital and Harvard Medical School, Boston, MA., El-Jawahri A; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Scarfò I; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Schmidts A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Haradhvala NJ; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA., Wehrli M; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Lee WH; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Parker AL; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Wiggin HR; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Bouffard A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Dey A; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Leick MB; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Katsis K; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Elder EL; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Dolaher MA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Cook DT; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Chekmasova AA; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Huang L; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA., Nikiforow S; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Connell and O'Reilly Families Cell Manipulation Core Facility, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Daley H; Connell and O'Reilly Families Cell Manipulation Core Facility, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Connell and O'Reilly Families Cell Manipulation Core Facility, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Armant M; TransLab, Boston Children's Hospital, Boston, MA., Preffer F; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., DiPersio JF; Department of Medicine, Washington University School of Medicine, St. Louis, MO., Nardi V; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Chen YB; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA., Gallagher KME; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Department of Pathology, Massachusetts General Hospital, Boston, MA., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA.; Department of Pathology and Department of Medicine, Harvard Medical School, Boston, MA.; Cancer Program, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
Publikováno v:
Blood [Blood] 2024 Sep 12; Vol. 144 (11), pp. 1153-1167.
Autor:
Louboutin JP; Department of Pathology, Thomas Jefferson University, Philadelphia, PA 19107, USA. jplouboutin@hotmail.com, Chekmasova AA, Reyes BA, Van Bockstaele EJ, Strayer DS
Publikováno v:
Neuroscience [Neuroscience] 2011 Nov 10; Vol. 195, pp. 215-23. Date of Electronic Publication: 2011 Aug 31.
Autor:
Marusich E; Department of Pathology, Jefferson Medical College, Thomas Jefferson University, 1020 Locust Street, Philadelphia, Pennsylvania 19107, USA., Louboutin JP, Chekmasova AA, Strayer DS
Publikováno v:
Journal of the neurological sciences [J Neurol Sci] 2011 Sep 15; Vol. 308 (1-2), pp. 25-7. Date of Electronic Publication: 2011 Jul 13.
Autor:
Louboutin JP; Department of Pathology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. jplouboutin@hotmail.com, Chekmasova AA, Marusich E, Chowdhury JR, Strayer DS
Publikováno v:
Nature methods [Nat Methods] 2010 Nov; Vol. 7 (11), pp. 905-7. Date of Electronic Publication: 2010 Oct 17.
Autor:
Chekmasova AA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA., Rao TD, Nikhamin Y, Park KJ, Levine DA, Spriggs DR, Brentjens RJ
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2010 Jul 15; Vol. 16 (14), pp. 3594-606. Date of Electronic Publication: 2010 Jul 13.